Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 23.52
+0.16 (0.68%)
Jul 10, 2026, 9:45 AM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 3.31 billion as of July 9, 2026.
Market Cap
3.31B
Enterprise Value
2.15B
Revenue
634.40M
Ranking
n/a
PE Ratio
12.89
Stock Price
23.52
Market Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.31B, a decrease of -24.16%. That is a compound annual growth rate of -23.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 3.31B | -23.36% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 3.87B |
| Guangzhou Innogen Pharmaceutical Group | 3.70B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.53B |
| Shandong Boan Biotechnology | 3.22B |
| Jiangsu Recbio Technology | 3.18B |
| Laekna | 3.03B |
| BioDlink International Company | 2.77B |